Vaximm appoints Dr Jarl Ulf Jungnelius as Chief Medical Officer Vaximm appoints Dr Jarl Ulf Jungnelius as Chief Medical Officer He has spent more than 30 years practising medicine and leading oncology drug development projects at pharma firms Key management changes aim to support future growth at Scancell Key management changes aim to support future growth at Scancell The firm also opens new US headquarters in San Diego Astellas names Rodrigo Fernandez as Executive Director, International Business Astellas names Rodrigo Fernandez as Executive Director, International Business Fernandez to lead Astellas' business in Latin America outside Brazil Sciformix names Fran Bates as VP of Technology Services Sciformix names Fran Bates as VP of Technology Services Appointment supports customer needs and future growth by offering technology services solutions focused on science Chief Commercial Officer appointed at Biohaven Chief Commercial Officer appointed at Biohaven John Tilton takes the newly created position at the US biopharmaceutical firm Glycotope appoints Dr Alfredo Zurlo as Chief Medical Officer Glycotope appoints Dr Alfredo Zurlo as Chief Medical Officer The company has a unique approach to the development of novel immuno-oncology candidates Dr Avinash Desai becomes VP, Americas Oncology Medical Affairs, Oncology Business Group at Eisai Inc Dr Avinash Desai becomes VP, Americas Oncology Medical Affairs, Oncology Business Group at Eisai Inc Desai has more than 20 years of experience in the oncology field New Chief Scientific Officer for AnaptysBio New Chief Scientific Officer for AnaptysBio Dr Matthew Moyle will be responsible for the discovery and early development of therapeutic antibodies generated using AnaptysBio's SHM-XEL platform Louis Yu joins AMRI as Senior Vice President, Quality and Compliance Louis Yu joins AMRI as Senior Vice President, Quality and Compliance He will oversee all aspects of quality and cGMP compliance across all divisions of AMRI AMO Pharma makes three new appointments AMO Pharma makes three new appointments All have widespread experience in the pharmaceutical industry Lumos Pharma appoints David Weiner as Chief Medical Officer Lumos Pharma appoints David Weiner as Chief Medical Officer He will steer the development of the company's rare and orphan disease therapeutics PCI Pharma Services welcomes Pieter-Jan Vos as Business Development Manager PCI Pharma Services welcomes Pieter-Jan Vos as Business Development Manager Joins the firm's international sales team Sandford Sommer joins Vernalis as President & Chief Operating Officer Sandford Sommer joins Vernalis as President & Chief Operating Officer Prior to joining the UK firm Sommer spent 24 years at AstraZeneca Edwin Klumper joins Cristal Therapeutics as Chief Medical Officer Edwin Klumper joins Cristal Therapeutics as Chief Medical Officer He will be responsible for the clinical strategy and development of Cristal Therapeutics’ nanomedicines Valeant Pharmaceuticals names Joseph Papa as Chairman and Chief Executive Valeant Pharmaceuticals names Joseph Papa as Chairman and Chief Executive He brings more than 30 years of leadership and operations experience in healthcare to the firm Paul Doody heads global marketing at Domino Printing Sciences Paul Doody heads global marketing at Domino Printing Sciences He brings a wealth of experience to the Cambridge, UK-based coding and marking specialist XenoGesis strengthens DMPK team with appointment of Peter White XenoGesis strengthens DMPK team with appointment of Peter White He specialises in mass spectrometry and bioanalysis Scottish CMO Symbiosis strengthens US presence Scottish CMO Symbiosis strengthens US presence Appoints Dr Thomas Scullion as US Business Development Manager David Lescuyer joins SkyePharma as Executive Vice President, Oral Business David Lescuyer joins SkyePharma as Executive Vice President, Oral Business He will be responsible for Skyepharma’s Oral Business including, after 30 June, the manufacturing operations in Saint-Quentin Fallavier, France Kymab hires leaders in immuno-oncology, infectious disease and blood disorders Kymab hires leaders in immuno-oncology, infectious disease and blood disorders Appointments bring internationally recognised expertise to strengthen Kymab’s key therapeutic areas Adapt Pharma names Mike Kelly as President of US operations Adapt Pharma names Mike Kelly as President of US operations He contributes more than 25 years of pharmaceutical expertise to Adapt executive team Dr Richard Butt to become CEO of Apollo Therapeutics Dr Richard Butt to become CEO of Apollo Therapeutics He will join the investment fund from Pfizer Neusentis Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult Quinn has been Chief Medical Officer of the organisation for the past six months Nigel Bond joins Brother executive management team Nigel Bond joins Brother executive management team Follows acquisition of Domino Printing Sciences by Japanese firm